What is it about?
Critically evaluate the existing evidence and present the conflicting recommendations related to postpartum Depo Provera (DP) use among breastfeeding women.
Featured Image
Why is it important?
Current evidence is methodologically weak and provides an inadequate basis for inferences about a possible causal relationship between early postpartum DP use and poor breastfeeding outcomes. However, given the strong biologic model describing the potential deleterious effect of postpartum DP use on lactation, further research is warranted. Meanwhile, we recommend potential breastfeeding risks associated with early DP use be disclosed to allow for a fully informed consent process.
Read the Original
This page is a summary of: A Systematic Review of Early Postpartum Medroxyprogesterone Receipt and Early Breastfeeding Cessation: Evaluating the Methodological Rigor of the Evidence, Breastfeeding Medicine, February 2012, Mary Ann Liebert Inc,
DOI: 10.1089/bfm.2011.0105.
You can read the full text:
Contributors
The following have contributed to this page